Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

xtend21

  • Home
  •  
  • xtend21



  • Most Read
  • Latest Comments
  • Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Apiam appoints Bruce Dixon as Director, strengthening leadership with Greencross expertise
    Apiam appoints Bruce Dixon as Director, strengthening leadership with Greencross expertise
    • News

  • Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    Bruce Dixon and Vita Pepe syndicate takes major position in Apiam Animal Health
    • News

  • Apiam Animal Health delivers record earnings, leverages animal data analytics and streamlines business to drive growth
    Apiam Animal Health delivers record earnings, leverages animal data analytics and streamlines business to drive growth
    • News

  • Apiam deploys revolutionary tick and flea preventative for Australian dog owners, a major growth driver for FY25
    Apiam deploys revolutionary tick and flea preventative for Australian dog owners, a major growth driver for FY25
    • News

  • Apiam Animal Health partners with Veyx-Pharma to distribute innovative products in Australia
    Apiam Animal Health partners with Veyx-Pharma to distribute innovative products in Australia
    • News

  • Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets
    • News

    Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets

    The US Environmental Protection Agency has granted regulatory label approval for the commercialisation of Xtend 21®– an innovative product that has been demonstrated by university studies to enhance long term antimicrobial surface protection. The pathway of Xtend 21® for the US market first commenced in March 2020 when Apiam Animal Health (ASX: AHX) was appointed the exclusive

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.